MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis LA Díaz, E Fuentes-López, G Ayares, F Idalsoaga, J Arnold, MA Valverde, ... JHEP Reports 5 (8), 100727, 2023 | 15 | 2023 |
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study W Dunn, Y Li, AK Singal, DA Simonetto, LA Díaz, F Idalsoaga, G Ayares, ... Hepatology 80 (5), 1196-1211, 2024 | 4 | 2024 |
OP-5 alcohol-associated hepatitis in Latin America: Results from the AH-Latin study LA Díaz, J Arnold, F Idalsoaga, G Ayares, M Ayala-Valverde, D Perez, ... Annals of Hepatology 28, 101054, 2023 | 1 | 2023 |
OP-5 ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) CRITERIA IN ALCOHOL-ASSOCIATED HEPATITIS: IMPLICATIONS FOR LIVER TRANSPLANTATION LAD PIGA, P Huerta, R Farias, B Alcayaga, F Idalsoaga, G Ayares, ... Annals of Hepatology 29, 101603, 2024 | | 2024 |
O-6 EXPLORING THE IMPACT OF INFECTIONS IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS IN LATIN AMERICA LA Díaz, F Idalsoaga, G Ayares, J Arnold, K Maldonado, M Ayala, D Perez, ... Annals of Hepatology 29, 101256, 2024 | | 2024 |
O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY F Idalsoaga, LA Díaz, G Ayares, J Arnold, W Dunn, Y Li, A Singal, ... Annals of Hepatology 28, 101035, 2023 | | 2023 |
ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY FJ Idalsoaga, LAD Piga, G Ayares, J Arnold, W Dunn, Y Li, AK Singal, ... HEPATOLOGY 76, S1009-S1011, 2022 | | 2022 |
ALCOHOL-ASSOCIATED HEPATITIS IN LATIN AMERICA: RESULTS FROM THE AH-LATIN STUDY L Antonio Diaz, J Arnold, F Javier Idalsoaga, G Ayares, M Ayala-Valverde, ... HEPATOLOGY 76, S1007-S1009, 2022 | | 2022 |